Outperform the Market with Zacks: Spotlight on Oracle, Intellia, and Pharming Group
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 02 2025
0mins
Source: NASDAQ.COM
Market Performance Overview: Major U.S. stock indexes closed lower last week, with the Dow, Nasdaq, and S&P 500 all experiencing slight declines, despite monthly gains. Investor sentiment was affected by profit-taking, inflation concerns, and geopolitical tensions.
Zacks Investment Research Highlights: Zacks reported strong performance from several stocks and portfolios, including significant gains from Dorian LPG and FS Bancorp, as well as the Zacks Focus List and Earnings Certain Admiral Portfolio outperforming the S&P 500 over various time frames.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like LITE with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on LITE
Wall Street analysts forecast LITE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LITE is 303.36 USD with a low forecast of 147.00 USD and a high forecast of 470.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
9 Buy
5 Hold
0 Sell
Moderate Buy
Current: 385.000
Low
147.00
Averages
303.36
High
470.00
Current: 385.000
Low
147.00
Averages
303.36
High
470.00
About LITE
Lumentum Holdings Inc. is a designer and manufacturer of optical and photonic products enabling optical networking and laser applications worldwide. Its segments include Cloud & Networking and Industrial Tech. The Cloud & Networking segment products include a comprehensive portfolio of optical and photonic components, modules, and subsystems supplied to cloud and communications network operators and network equipment manufacturers building cloud data center infrastructure, including products for artificial intelligence and machine learning (AI/ML) and data center interconnect (DCI) applications, and communications service provider networks, including products for access (local), metro (intracity), long-haul (city-to-city and worldwide), and submarine (undersea) network infrastructure. The Industrial Tech segment products include solid-state lasers, kilowatt-class fiber lasers, diode lasers, ultrafast lasers, and gas lasers, which address applications in numerous end-markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street Gains Momentum as Corporate Earnings Boost Risk Appetite
- S&P 500 Hits Record High: The S&P 500 index reached 6,990 during midday trading in New York, marking a new all-time high, as upbeat corporate earnings boosted market risk appetite and investor confidence.
- Nasdaq 100 Continues to Rise: The Nasdaq 100 index gained 1.1% for the fifth consecutive session, reaching 26,000 and nearing its October record of 26,182, reflecting strong performance in technology stocks.
- Healthcare Stocks Plummet: Shares of health insurers like UnitedHealth fell nearly 20% following a proposed Medicare payment update from the Trump administration, indicating a negative impact on future revenue and margins in the sector.
- General Motors Surges on Earnings: General Motors' stock rose over 8% after beating earnings forecasts and providing optimistic guidance for 2026, highlighting the potential for recovery in the automotive sector and market confidence in its future growth.
Continue Reading
HCA Healthcare Surges After Strong Q4 Earnings and Upgraded FY25 Guidance
- Earnings Beat: HCA Healthcare reported an adjusted EPS of $8.01 for Q4, surpassing the analyst consensus of $7.43, indicating robust profitability and strong market demand.
- Stock Surge: Following the earnings report, HCA's shares jumped 9.5% to $517.00 on Tuesday, reflecting investor confidence in the company's future growth prospects.
- Upgraded Guidance: The company raised its FY25 guidance above estimates, signaling a positive outlook for business development that may attract more investor interest.
- Positive Market Reaction: HCA's favorable news boosted overall market confidence in the healthcare sector, potentially leading to further gains in related stocks.
Continue Reading